The key findings of the study, conducted in the world’s largest BD cohort with genotypic and phenotypic data, offer potential sleep-related genetic underpinnings for BD diagnostic groups.
Individual and coexisting symptoms of insomnia are associated with increased risk for cardio-cerebral vascular diseases.
Cognitive behavioral therapy (CBT) may reduce the incidence of insomnia symptoms in adolescents, according to study data presented at the 2019 World Sleep Congress.
Investigators sought to determine the mental health needs of evacuees of devastating wildfires in Canada and to distribute evidence-based tools to promote resilience.
Researchers find once-daily treatment with lemborexant is associated with a noticeable reduction in subject-reported fatigue over 6 month period in patients with insomnia disorder.
A stepped care approach seems beneficial for insomnia treatment among cancer survivors.
In this single-center, prospective, cross-sectional cohort study, the authors aimed to compare the efficacy of zolpidem to melatonin in the treatment of hospital-related insomnia.
A new Boxed Warning will be required in the prescribing information for several insomnia medications following reports of serious injuries and deaths associated with complex sleep behaviors where patients engaged in activities while not fully awake.
The NDA includes data from two Phase 3 clinical trials (SUNRISE 1 and SUNRISE 2) which included approximately 2000 patients.
SUNRISE 2 is an ongoing long-term efficacy and safety study (N=900) of adults (aged 18 to 88 years) with insomnia disorder who have difficulty falling and/or staying asleep.
